Bilirubin Level is Associated with Left Ventricular Hypertrophy Independent of Blood Pressure in Previously Untreated Hypertensive Patients

AYAZ T., Durakoglugil M. E., KOCAMAN S. A., DURAKOGLUGIL T., Erdoğan T., Sahin O. Z., ...More

KOREAN CIRCULATION JOURNAL, vol.44, no.5, pp.336-343, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 44 Issue: 5
  • Publication Date: 2014
  • Doi Number: 10.4070/kcj.2014.44.5.336
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.336-343
  • Keywords: Hypertension, Left ventricular hypertrophy, Uric acid, Bilirubin, Waist circumference, SERUM URIC-ACID, METABOLIC SYNDROME, CARDIOVASCULAR-DISEASE, MOLECULAR-MECHANISMS, RISK, MASS, POPULATION, REGRESSION, EVENTS, IMPACT
  • Recep Tayyip Erdoğan University Affiliated: Yes


Background and Objectives: Left ventricular hypertrophy (LVH), a sign of subclinical cardiovascular disease, is an important predictor of cardiovascular morbidity and mortality. The aim of our study was to determine the association of left ventricular mass (LVM) with possible causative anthropometric and biochemical parameters as well as carotid intima-media thickness (CIMT) and brachial flow-mediated dilation (FMD) as surrogates of atherosclerosis and endothelial dysfunction, respectively, in previously untreated hypertensive patients.